ethylisopropylamiloride has been researched along with Seizures in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, SM | 1 |
| Schreiner, CM | 1 |
| Schultheis, PJ | 1 |
| Miller, ML | 1 |
| Evans, RL | 1 |
| Vorhees, CV | 1 |
| Shull, GE | 1 |
| Scott, WJ | 1 |
1 other study available for ethylisopropylamiloride and Seizures
| Article | Year |
|---|---|
Targeted disruption of the murine Nhe1 locus induces ataxia, growth retardation, and seizures.
Topics: Amiloride; Animals; Ataxia; Base Sequence; Body Weight; Chimera; Crosses, Genetic; Death; Embryonic | 1999 |